These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1036 related articles for article (PubMed ID: 24998011)
21. Selective serotonin reuptake inhibitors and tricyclic antidepressants in combination. Interactions and therapeutic uses. Taylor D Br J Psychiatry; 1995 Nov; 167(5):575-80. PubMed ID: 8564311 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview. Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236 [TBL] [Abstract][Full Text] [Related]
24. Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs. Hirschfeld RM J Clin Psychiatry; 1999 May; 60(5):326-35. PubMed ID: 10362442 [TBL] [Abstract][Full Text] [Related]
25. Effects of selective serotonin reuptake inhibitors versus tricyclic antidepressants on cerebrovascular events: a nationwide population-based cohort study. Lee YC; Lin CH; Lin MS; Lin JW; Chang CH; Lai MS J Clin Psychopharmacol; 2013 Dec; 33(6):782-9. PubMed ID: 24091857 [TBL] [Abstract][Full Text] [Related]
26. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs). Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis. MacGillivray S; Arroll B; Hatcher S; Ogston S; Reid I; Sullivan F; Williams B; Crombie I BMJ; 2003 May; 326(7397):1014. PubMed ID: 12742924 [TBL] [Abstract][Full Text] [Related]
28. Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials. Sussman N; Ginsberg DL; Bikoff J J Clin Psychiatry; 2001 Apr; 62(4):256-60. PubMed ID: 11379839 [TBL] [Abstract][Full Text] [Related]
29. Treatment of Functional Abdominal Pain With Antidepressants: Benefits, Adverse Effects, and the Gastroenterologist's Role. Zar-Kessler CAM; Belkind-Gerson J; Bender S; Kuo BM J Pediatr Gastroenterol Nutr; 2017 Jul; 65(1):16-21. PubMed ID: 28644344 [TBL] [Abstract][Full Text] [Related]
30. Antidepressants for people with epilepsy and depression. Maguire MJ; Weston J; Singh J; Marson AG Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360 [TBL] [Abstract][Full Text] [Related]
31. Serum levels and cardiovascular effects of tricyclic antidepressants and selective serotonin reuptake inhibitors in depressed patients. Rodriguez de la Torre B; Dreher J; Malevany I; Bagli M; Kolbinger M; Omran H; Lüderitz B; Rao ML Ther Drug Monit; 2001 Aug; 23(4):435-40. PubMed ID: 11477329 [TBL] [Abstract][Full Text] [Related]
32. Tricyclic antidepressants and selective serotonin reuptake inhibitors: use during pregnancy, in children/adolescents and in the elderly. Emslie G; Judge R Acta Psychiatr Scand Suppl; 2000; 403():26-34. PubMed ID: 11019932 [TBL] [Abstract][Full Text] [Related]
33. Antidepressants for people with epilepsy and depression. Maguire MJ; Marson AG; Nevitt SJ Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531 [TBL] [Abstract][Full Text] [Related]
34. Milnacipran and selective serotonin reuptake inhibitors in major depression. Lopez-Ibor J; Guelfi JD; Pletan Y; Tournoux A; Prost JF Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():41-6. PubMed ID: 8923126 [TBL] [Abstract][Full Text] [Related]
35. Co-prescribing of SSRIs and TCAs in Australia: how often does it occur and who is doing it? McManus P; Mant A; Mitchell P; Birkett D; Dudley J Br J Clin Pharmacol; 2001 Jan; 51(1):93-8. PubMed ID: 11167670 [TBL] [Abstract][Full Text] [Related]
36. A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs and TCAs. Doyle JJ; Casciano J; Arikian S; Tarride JE; Gonzalez MA; Casciano R Value Health; 2001; 4(1):16-31. PubMed ID: 11704969 [TBL] [Abstract][Full Text] [Related]
37. Does the use of SSRIs reduce medical care utilization and expenditures? Chung S J Ment Health Policy Econ; 2005 Sep; 8(3):119-29. PubMed ID: 16278500 [TBL] [Abstract][Full Text] [Related]
38. Clinical implications of the pharmacology of serotonin reuptake inhibitors. Warrington SJ Int Clin Psychopharmacol; 1992 Oct; 7 Suppl 2():13-9. PubMed ID: 1484174 [TBL] [Abstract][Full Text] [Related]
39. Treatment options in the management of adolescent depression. Weller EB; Weller RA J Affect Disord; 2000 Dec; 61 Suppl 1():23-8. PubMed ID: 11155965 [TBL] [Abstract][Full Text] [Related]
40. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Peet M Br J Psychiatry; 1994 Apr; 164(4):549-50. PubMed ID: 8038948 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]